Allergan's Ocuflox receives marketing approval for treating corneal ulcers.

Business WireMay 28, 1996

Linked as:

Extract


Allergan's Ocuflox receives marketing approval for treating corneal ulcers.

IRVINE, Calif.--(BUSINESS WIRE)--May 28, 1996--Allergan Inc. (NYSE:...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company